Drug Profile
RO 5267683
Alternative Names: RO5267683Latest Information Update: 25 Feb 2014
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 25 Feb 2014 Discontinued - Phase-I for Undefined indication in France (PO)
- 30 Jun 2012 Roche completes a phase I trial in Healthy volunteers in France (NCT01398241)
- 31 Aug 2011 Phase-I clinical trials in Undefined indication in France (PO)